Drug Shortage Report for GLUCAGON

Last updated on 2023-01-28 History
Report ID 180461
Drug Identification Number 02243297
Brand name GLUCAGON
Common or Proper name Glucagon for Injection, rDNA origin
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) GLUCAGON
Strength(s) 1MG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size Kit containing 1 mg glucagon sterile lyophilized powder in a 3 mL vial and 1 mL prefilled diluent syringe
ATC code H04AA
ATC description GLYCOGENOLYTIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-01-10
Estimated end date 2023-02-06
Actual end date 2023-01-27
Shortage status Resolved
Updated date 2023-01-28
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-01-28 English Compare
v5 2023-01-27 French Compare
v4 2023-01-27 English Compare
v3 2023-01-11 English Compare
v2 2023-01-10 French Compare
v1 2023-01-10 English Compare

Showing 1 to 6 of 6